跳至主要内容
临床试验/IRCT2016081811763N30
IRCT2016081811763N30已完成未知

The effect of Q10 supplementation on metabolic profile, inflammatory marker and oxidative stress in diabetic hemodialysis patients

Vice chancellor for research, Isfahan University of Medical Sciences0 个研究点目标入组 70 人开始时间: 待定最近更新:
适应症

试验速览

阶段
未知
状态
已完成
发起方
入组人数
70

研究概览

简要总结

暂无简介。

研究设计

研究类型
Interventional

入排标准

年龄范围
45 years 至 75 years(—)
性别
All

入选标准

  • 1- hemodialysis patients with glomerular filtration rate less than 10 or 25 ml/min with malnutrition and hypercalemy.
  • 2- aged 45-75.
  • 3-average blood pressure (systolic pressure 140-160 mmHg , diastolic pressure 90-100 mmHg)
  • 4-diabetic patients according to American diabetes assossiation criteria.
  • Exclusion criteria: 1-unwilling to cooperate
  • 2- hyperthyroidism and hypothyroidism
  • 3-specific disease leading to bed.
  • 4-malignant hypertension (systolic pressure more than 160 mmHg and diastolic pressure more than 100mmHg)

排除标准

  • 未提供

研究者

发起方
Vice chancellor for research, Isfahan University of Medical Sciences

相似试验

effect of supplementation in treatment of diabetic... | 临床试验